Facephi Biometria (BME:FACE) First Half 2022 Results
Main financial results
- Turnover: €9.72m (+98% compared to 1H 2021).
- Net loss: €1.07m (loss reduced by 37% compared to H1 2021).
All figures shown in the table above are for the 12 month period (TTM)
Facephi Biometria Revenue Outlook
Going forward, revenue is expected to grow by an average of 15% per year over the next 3 years, compared to a growth forecast of 9.1% for the software industry in Europe.
Market performance in Spain.
Shares of the company are down 1.9% from a week ago.
Risk analysis
Before concluding, we discovered 4 warning signs for Facephi Biometria (1 is a little unpleasant!) which you should be aware of.
Valuation is complex, but we help make it simple.
Find out if Facephi Biometrics is potentially overvalued or undervalued by viewing our full analysis, which includes fair value estimates, risks and warnings, dividends, insider trading and financial health.
See the free analysis
Feedback on this article? Concerned about content? Get in touch with us directly. You can also email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.
Comments are closed.